Literature DB >> 4127759

Vertebrate collagenase: further characterization and the significance of its latent form in vivo.

Y Nagai.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4127759     DOI： 10.1007/bf01659325

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN： 0300-8177            Impact factor:   3.396


× No keyword cloud information.
  36 in total

1.  Collagenolytic activity in amphibian tissues: a tissue culture assay.

Authors:  J GROSS; C M LAPIERE
Journal:  Proc Natl Acad Sci U S A       Date:  1962-06-15       Impact factor: 11.205

2.  Vertebrate collagenase: direct extraction from animal skin and human synovial membrane.

Authors:  Y Nagai; H Hori
Journal:  J Biochem       Date:  1972-11       Impact factor: 3.387

3.  Human gingival collagenase: purification, molecular weight, and inhibitor studies.

Authors:  H M Fullmer; R E Taylor; R W Guthrie
Journal:  J Dent Res       Date:  1972 Mar-Apr       Impact factor: 6.116

Review 4.  Collagen, collagenase and clinicians.

Authors:  G S Lazarus
Journal:  Br J Dermatol       Date:  1972-02       Impact factor: 9.302

5.  Properties of a collagen molecule containing three identical components extracted from bovine articular cartilage.

Authors:  E Strawich; M E Nimni
Journal:  Biochemistry       Date:  1971-10-12       Impact factor: 3.162

Review 6.  Collagenase and rheumatoid arthritis.

Authors:  E D Harris; J M Evanson; D R DiBona; S M Krane
Journal:  Arthritis Rheum       Date:  1970 Jan-Feb

7.  Evidence for the presence of a complex of collagenase with alpha2-macroglobulin in human rheumatoid synovial fluid: a possible regulatory mechanism of collagenase activity in vivo.

Authors:  S Abe; Y Nagai
Journal:  J Biochem       Date:  1973-04       Impact factor: 3.387

8.  Synovial collagenase: its presence in culture from joint disease of diverse etiology.

Authors:  E D Harris; G L Cohen; S M Krane
Journal:  Arthritis Rheum       Date:  1969-04

9.  Studies on purified rheumatoid synovial collagenase in vitro and in vivo.

Authors:  E A Bauer; A Z Eisen; J J Jeffrey
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

10.  Characterization of a neutral protease from lysosomes of rabbit polymorphonuclear leucocytes.

Authors:  P Davies; G A Rita; K Krakauer; G Weissmann
Journal:  Biochem J       Date:  1971-07       Impact factor: 3.857
View more
  8 in total

1.  Evidence that latent collagenases are enzyme-inhibitor complexes.

Authors:  A Sellers; E Cartwright; G Murphy; J J Reynolds
Journal:  Biochem J       Date:  1977-05-01       Impact factor: 3.857

2.  Identification and partial characterization of an inhibitor of collagenase from rabbit bone.

Authors:  A Sellers; J J Reynolds
Journal:  Biochem J       Date:  1977-11-01       Impact factor: 3.857

3.  Pathology of collagen degradation. A review.

Authors:  R Pérez-Tamayo
Journal:  Am J Pathol       Date:  1978-08       Impact factor: 4.307

4.  Procollagenase activator produced by rabbit uterine cervical fibroblasts.

Authors:  M Ishibashi; A Ito; K Sakyo; Y Mori
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

5.  Rabbit collagenase. Immunological identity of the enzymes released from cells and tissues in normal and pathological conditions.

Authors:  Z Werb; J J Reynolds
Journal:  Biochem J       Date:  1975-12       Impact factor: 3.857

6.  Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation.

Authors:  Y Eeckhout; G Vaes
Journal:  Biochem J       Date:  1977-07-15       Impact factor: 3.857

7.  Effect of tensile mechanical stress on the synthesis of metalloproteinases by rabbit coronal sutures in vitro.

Authors:  M C Meikle; A Sellers; J J Reynolds
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

8.  Collagenase and collagenase inhibitors in osteoarthritic and normal cartilage.

Authors:  M G Ehrlich; H J Mankin; H Jones; R Wright; C Crispen; G Vigliani
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.